TherapeuticsMD Inc. (TXMD)
NASDAQ: TXMD
· Real-Time Price · USD
1.08
-0.02 (-1.82%)
At close: Jun 03, 2025, 3:57 PM
1.11
2.78%
After-hours: Jun 03, 2025, 07:49 PM EDT
TherapeuticsMD Revenue Breakdown
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|
| License Revenue | 1.3M | 69.96M | 1.17M |
| License Revenue Growth | -98.14% | +5874.64% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 |
|---|---|
| Non-Us Revenue | 638K |
| Non-Us Revenue Growth | n/a |
| United States Revenue | 1.12M |
| United States Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.08M | 879K | 1.31M | 1.23M | 1.32M | 1.48M | 1.59M | 2.78M | 3.06M | -59.24M | 36.76M | 41.08M | 39.3M | 47.91M | 58.44M | 52.04M | 42.41M | 48.95M | 38.75M | 48.34M | 56.93M | 52.73M | 45.13M | 41.39M | 34.86M | 35.41M | 30.35M | 29.47M | 20.76M | 14.18M | 12.06M | 14.63M | 16.84M | 16.33M | 14.72M | 10.62M | 9.68M | 8.63M | 7.06M | 6.87M | 6.16M |
| Selling, General, and Administrative Revenue Growth | +22.98% | -32.90% | +6.24% | -6.73% | -10.43% | -7.17% | -42.83% | -9.00% | -105.16% | -261.15% | -10.51% | +4.53% | -17.97% | -18.01% | +12.30% | +22.71% | -13.36% | +26.31% | -19.84% | -15.08% | +7.95% | +16.86% | +9.04% | +18.71% | -1.54% | +16.66% | +3.01% | +41.96% | +46.39% | +17.59% | -17.58% | -13.12% | +3.11% | +10.92% | +38.64% | +9.72% | +12.13% | +22.24% | +2.85% | +11.39% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.09M | 1.11M | 1.58M | 1.4M | 1.42M | 1.6M | 2.01M | 2.05M | 2.39M | 2.03M | 2.74M | 3.27M | 4.43M | 4.08M | 4.96M | 6.32M | 6.75M | 6.71M | 6.8M | 7.04M | 10.97M | 6.44M | 8.72M | 7.72M | 10.34M | 14.66M | 13.84M | 15.1M | 13.25M | 16.42M | 24.19M | 18.18M |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100.00% | -467.99% | -29.62% | +12.86% | -1.41% | -11.53% | -20.19% | -1.90% | -14.36% | +18.09% | -26.07% | -16.12% | -26.25% | +8.69% | -17.86% | -21.42% | -6.45% | +0.67% | -1.33% | -3.42% | -35.86% | +70.50% | -26.15% | +12.84% | -25.30% | -29.48% | +5.95% | -8.32% | +13.91% | -19.29% | -32.12% | +33.09% | n/a |